Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey
This study revealed significant variation in OPAT practice. Further study is needed to understand the reasons for these differences and whether better alignment of practice could improve patient outcomes, antimicrobial stewardship practice and resource utilization.
Authors
- Jason A. Roberts (ORCID: https://orcid.org/0000-0001-6218-435X)
- Luis Eduardo López-Cortés (ORCID: https://orcid.org/0000-0002-9347-527X)
- R.A. Seaton (ORCID: https://orcid.org/0000-0002-2509-0597)
- Mohd H. Abdul‐Aziz (ORCID: https://orcid.org/0000-0002-8889-5579)
- Fekade B. Sime (ORCID: https://orcid.org/0000-0003-4061-2063)
- Afra Nahdia Marizan Nor (ORCID: https://orcid.org/0009-0003-9877-0467)
- James Pollard (ORCID: https://orcid.org/0000-0001-9984-2870)
- Manuel Mirón-Rubio (ORCID: https://orcid.org/0000-0003-0440-6174)
- C Jamieson (ORCID: https://orcid.org/0009-0003-3029-4484)
- Zenaw T Wolie
- Mary J.R. Gilchrist
Institutions
- Imperial College Healthcare NHS Trust (GB)
- The University of Queensland (AU)
- Université de Montpellier (FR)
- Royal Brisbane and Women's Hospital (AU)
- British Society for Antimicrobial Chemotherapy (GB)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario de Torrejón (ES)
- Hospital Universitario Virgen Macarena (ES)
- Cabrini Hospital (AU)
- Infectious Diseases Institute (UG)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Sungai Buloh (MY)
- Spanish Society of Hematology and Hemotherapy (ES)
- Queen Elizabeth University Hospital (GB)
- NHS England
- Imperial College London (GB)
- Université de Nîmes (FR)
- Universidad de Sevilla (ES)
- Debre Markos University (ET)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/jacamr/dlaf075
- Citations
- 4
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 5.58
Funders
- Pfizer
- Gilead Sciences
- British Society for Antimicrobial Chemotherapy
- Medical Research Council
- National Health and Medical Research Council